Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj
Clinical trial NCT02532569 · COMPLETED
Trial details
- NCT number
- NCT02532569
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-10-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.